Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Forst

Showing results (131-140 of 148) with videos related to

Pageof 15
Sort By:
Journal of Diabetes Science and Technology|November 8, 2023
The Role of Ultra-Rapid-Acting Insulin Analogs in Diabetes: An Expert ConsensusFrancesco Giorgino, Tadej Battelino, Richard M Bergenstal, et al.
Diabetes, Obesity & Metabolism|February 11, 2025
Novel pharmacotherapies for weight loss: Understanding the role of incretins to enable weight loss and improved health outcomesThomas Forst, Christophe De Block, Stefano Del Prato, et al.
Lancet (London, England)|June 8, 2026
Orforglipron compared with dapagliflozin in adults with type 2 diabetes and inadequate glycaemic control with metformin (ACHIEVE-2): a multicentre, randomised, non-inferiority, open-label, phase 3 trialMichelle Welch, Thomas Forst, Weiping Jia, et al.
Clinical Laboratory|April 24, 2007
Relaxin expression correlates significantly with serum changes in VEGF in response to antidiabetic treatment in male patients with type 2 diabetes mellitusThomas Schöndorf, Thomas Forst, Cloth Hohberg, et al.
Diabetes Care|April 19, 2015
Contrasting Effects of Lixisenatide and Liraglutide on Postprandial Glycemic Control, Gastric Emptying, and Safety Parameters in Patients With Type 2 Diabetes on Optimized Insulin Glargine With or Without Metformin: A Randomized, Open-Label TrialJuris J Meier, Julio Rosenstock, Agnès Hincelin-Méry, et al.
Journal of Diabetes Science and Technology|August 19, 2024
Performance of a Novel Continuous Glucose Monitoring Device in People With DiabetesJulia K Mader, Delia Waldenmaier, Wiebke Mueller-Hoffmann, et al.
Journal of Diabetes Science and Technology|October 10, 2017
Acceptability of Implantable Continuous Glucose Monitoring SensorKatharine D Barnard, Jort Kropff, Pratik Choudhary, et al.
Endocrine|December 2, 2016
Endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNA) in insulinomas: Indications and clinical relevance in a single investigator cohort of 47 patientsPeter Herbert Kann, Roland Moll, Detlef Bartsch, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|July 10, 2007
Relaxin expression correlates significantly with serum fibrinogen variation in response to antidiabetic treatment in women with type 2 diabetes mellitusThomas Schöndorf, Georg Lübben, Markus Hoopmann, et al.
BMC Medicine|October 9, 2022
New strategies to improve clinical outcomes for diabetic kidney diseaseThomas Forst, Chantal Mathieu, Francesco Giorgino, et al.
Pageof 15

Showing results (131-140 of 148) with videos related to

Sort By:
Pageof 15
Journal of Diabetes Science and Technology|November 8, 2023
The Role of Ultra-Rapid-Acting Insulin Analogs in Diabetes: An Expert ConsensusFrancesco Giorgino, Tadej Battelino, Richard M Bergenstal, et al.
Diabetes, Obesity & Metabolism|February 11, 2025
Novel pharmacotherapies for weight loss: Understanding the role of incretins to enable weight loss and improved health outcomesThomas Forst, Christophe De Block, Stefano Del Prato, et al.
Lancet (London, England)|June 8, 2026
Orforglipron compared with dapagliflozin in adults with type 2 diabetes and inadequate glycaemic control with metformin (ACHIEVE-2): a multicentre, randomised, non-inferiority, open-label, phase 3 trialMichelle Welch, Thomas Forst, Weiping Jia, et al.
Clinical Laboratory|April 24, 2007
Relaxin expression correlates significantly with serum changes in VEGF in response to antidiabetic treatment in male patients with type 2 diabetes mellitusThomas Schöndorf, Thomas Forst, Cloth Hohberg, et al.
Diabetes Care|April 19, 2015
Contrasting Effects of Lixisenatide and Liraglutide on Postprandial Glycemic Control, Gastric Emptying, and Safety Parameters in Patients With Type 2 Diabetes on Optimized Insulin Glargine With or Without Metformin: A Randomized, Open-Label TrialJuris J Meier, Julio Rosenstock, Agnès Hincelin-Méry, et al.
Journal of Diabetes Science and Technology|August 19, 2024
Performance of a Novel Continuous Glucose Monitoring Device in People With DiabetesJulia K Mader, Delia Waldenmaier, Wiebke Mueller-Hoffmann, et al.
Journal of Diabetes Science and Technology|October 10, 2017
Acceptability of Implantable Continuous Glucose Monitoring SensorKatharine D Barnard, Jort Kropff, Pratik Choudhary, et al.
Endocrine|December 2, 2016
Endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNA) in insulinomas: Indications and clinical relevance in a single investigator cohort of 47 patientsPeter Herbert Kann, Roland Moll, Detlef Bartsch, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|July 10, 2007
Relaxin expression correlates significantly with serum fibrinogen variation in response to antidiabetic treatment in women with type 2 diabetes mellitusThomas Schöndorf, Georg Lübben, Markus Hoopmann, et al.
BMC Medicine|October 9, 2022
New strategies to improve clinical outcomes for diabetic kidney diseaseThomas Forst, Chantal Mathieu, Francesco Giorgino, et al.
Pageof 15